Cargando…
681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies
BACKGROUND: Synergistic ampicillin plus ceftriaxone (AC) for Enterococcus faecalis infective endocarditis outpatient use is precluded by ampicillin’s poor room temperature stability. Penicillin has superior stability and has been combined with ceftriaxone (PC), however there is a lack of studies to...
Autores principales: | Khan, Ruhmazia, Shah, Zeel, Huang, Vanthida, Cusumano, Jaclyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644852/ http://dx.doi.org/10.1093/ofid/ofab466.878 |
Ejemplares similares
-
Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates
por: Cusumano, Jaclyn A., et al.
Publicado: (2022) -
1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022) -
In Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis
por: Thieme, Lara, et al.
Publicado: (2021) -
1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019) -
184. Implications of Enterococcus faecalis penicillin susceptibility in patients with bacteremia
por: Hedvat, Jason, et al.
Publicado: (2023)